• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. JOURNEY TIBIA BASE NP RT SZ 6; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. JOURNEY TIBIA BASE NP RT SZ 6; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL Back to Search Results
Catalog Number 74022216
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arthralgia (2355); Ambulation Difficulties (2544); Inadequate Osseointegration (2646); Swelling/ Edema (4577)
Event Type  Injury  
Manufacturer Narrative
H10: internal complaint reference: case (b)(4).
 
Event Description
It was reported that, after a left knee replacement with journey ii bcs system had been performed on an unspecified date, the patient has stated that he cannot live with the pain that it causes every time he bends the knee or walks.The patient has also claimed that (i) the surgeon who implanted the system did not address the reactions he experienced on the knee at first, so he consulted another surgeon for a second opinion; (ii) the new surgeon indicated that the knee requires a revision surgery, which will be performed in may; (iii) something not right there and nobody seems to know how to fix it, although he believes that the problem is the insert because his research showed that s+n has recalled similar parts.The event is ongoing.
 
Manufacturer Narrative
H3, h6: given the nature of the alleged incident, the devices could not be returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that the provided x-ray appears to show bilateral total knee arthroplasties with scattered heterotopic bone formation (predominantly around the tibial baseplates) with possible bilateral radiolucency at inferolateral tibial baseplates and the left insert appears thicker than the right.Hardware (3 screws) noted in right lateral tibia as well as radiolucency under the lateral baseplate.There is ossification in both the medial and lateral soft tissue bilaterally.Patient provided an undated/unidentified phone screenshot of (b)(6) 2023 assessment which indicates a bilateral inflammatory reaction with suspected mechanical loosening as the cause for pain and swelling without any concern for infection.Based on the documentation provided, the patient¿s right knee symptoms are likely due to the suspected mechanical loosening.The length of time between symptom onset and proposed intervention likely contributes to the severity of the symptoms.Based on the patient¿s contralateral total knee arthroplasty history, possible ligament laxity and progression of disease cannot be ruled out as potential contributing factors, as well.The patient is to undergo a revision in may 2024; therefore, the event is ongoing and unresolved.The patient impact includes the reported suspected mechanical loosening with ongoing pain and swelling with an anticipated right knee revision.No further impact can be determined at this time.A review of the production orders did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history for the part numbers over the past 12 months and for the batch numbers based on historical data of the device did not reveal similar events for the listed devices.A review of the risk management files revealed this failure mode was previously identified.A review of previous actions concluded that there is a higher than expected risk of revision surgery when the patella is unresurfaced at the index surgery.Patella resurfacing is an intraoperative discretionary decision of the surgeon, and this clinical decision may mitigate risk for individual patients.Actions were taken to update the instructions for use document and surgical technique to include statements informing users that outcome data reported in some registries suggest that resurfacing the patella during primary total knee arthroplasty should be considered since it may decrease the rate of revision, provided the patient¿s anatomical and clinical conditions allow.The review of the instructions for use documents for knee systems also revealed in the warnings and precautions section states that correct selection of the implant is extremely important.The appropriate type and size should be selected for patients with consideration of anatomical and biomechanical factors such as patient age and activity levels, weight, bone and muscle conditions, etc.Failure to use the optimum size component may result in loosening, bending, cracking, or fracture of the component and/or bone.Moreover, the possible adverse effects section revealed that unusual stress concentrations can result from trauma, improper implant selection, improper implant positioning, improper fixation, and/or migration of the components.Muscle and fibrous tissue laxity can also contribute to these conditions.At this time, we have no evidence to conclude that the products failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include possible ligament laxity, progression of disease, abnormal motion over time, bone degeneration, inadequate integration between the cement and bone/implant, osteolysis and/or traumatic injury.Based on this investigation, the need for corrective action is not indicated.Should additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Manufacturer Narrative
Additional information: g2 (medwatch report reference number added), g3/g4 (pma/510(k)number) corrected data: b5, e4 (initial reporter also sent report to fda?), g2, h6 (health effect - clinical code).
 
Event Description
It was reported that, after a left knee replacement with journey ii bcs system had been performed on an unspecified date, the patient has stated that he cannot live with the pain that it causes every time he bends the knee or walks.The patient has also claimed that (i) the surgeon who implanted the system did not address the reactions he experienced on the knee at first, so he consulted another surgeon for a second opinion; (ii) the new surgeon indicated that the knee requires a revision surgery, which will be performed in (b)(6) 2024; (iii) something not right there and nobody seems to know how to fix it, although he believes that the problem is the insert because his research showed that s+n has recalled similar parts.The event is ongoing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JOURNEY TIBIA BASE NP RT SZ 6
Type of Device
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key18927164
MDR Text Key337945887
Report Number1020279-2024-00561
Device Sequence Number1
Product Code JWH
UDI-Device Identifier03596010554307
UDI-Public03596010554307
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K042515
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 04/11/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number74022216
Device Lot Number18AM14158
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/18/2024
Supplement Dates Manufacturer Received02/26/2024
04/03/2024
04/09/2024
Supplement Dates FDA Received04/01/2024
04/05/2024
04/11/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/19/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PN: 74022116 / LOT: 17KM12718.; PN: 74027253 / LOT: 17DM08108.
Patient Outcome(s) Other;
Patient Age52 YR
Patient SexMale
-
-